Acclinate
PrivateLast Round
Series A
May 7, 2024
Est. Valuation
$20M
Total Funding Raised
$10.92M
Company Overview
Acclinate is a digital health company that provides a platform leveraging machine learning and predictive analytics to enhance representation and diversity in genomic research and clinical trials by automating participant identification, education, engagement, and retention.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Patient Engagement, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Acclinate Comparables
Compare Acclinate with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Karneyium Health | 76% | |
| COUCH Health | 72% | |
| Syneos Health | 71% |
Acclinate Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 7, 2024 | ||||
| Seed | Nov 1, 2022 | ||||
| Grant | Oct 14, 2022 | ||||
| Grant | Oct 1, 2021 | ||||
| Accelerator | Feb 5, 2021 | ||||
Pre Seed | Sep 15, 2020 |
Key People
Founding team and executive leadership
Acclinate Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Overline | Seed |
| Latimer Ventures | Series A |
| Techstars | Accelerator, Seed |
| Google for Startups Black Founders Fund | Grant |
| Alabama Launchpad | Grant |
| Black Star Fund | Seed |
| Google for Startups Accelerator | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 16, 2026
Co-Founder Tiffany Whitlow named to Inc.'s 2026 Female Founders 500 list.
- Mar 16, 2026
NOWINCLUDED Unfiltered podcast aims to expand community footprint.
Acclinate Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Acclinate's valuation, stock price, and market status.
Is Acclinate a public or private company?
Acclinate is a private company.
What is the current stock price of Acclinate?
Acclinate is a private company with no public stock price. No recent secondary market data is available.
How much is Acclinate worth (valuation)?
Acclinate's valuation is estimated at $20.0M based on funding round data.
Can I buy Acclinate stock?
Acclinate shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Acclinate's last funding round?
Acclinate's most recent funding round was Series A on November 1, 2022.
Who are the main investors in Acclinate?
Key investors in Acclinate include Overline.
Will Acclinate IPO soon?
No public IPO plans have been announced for Acclinate.
How can I track Acclinate secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Acclinate's secondary market activity and sign up for updates.